ProofPilot, the leading solution to create simple and predictable clinical trials, is proud to announce its CEO, Chris Venezia, has joined the Board of Directors for RealTime eClinical Solutions. Venezia, a long-standing leader in clinical research technology, brings extensive experience in advancing clinical trial solutions to address the evolving challenges in the clinical research industry.
Venezia joins RealTime eClinical Solutions at a pivotal moment, as new leadership builds even stronger connections between sites and sponsors. According to RealTime eClinical’s new CEO, Jeff Kozloff, “Reducing site burden and accelerating site operations requires sponsors to invest in data and platforms that improve protocol planning, feasibility, and trial execution. Chris’s experience partnering with sponsors and CROs to enable site success will unlock tremendous value for RealTime’s global site community.”
Chris brings two decades of strong leadership in product development, commercialization, marketing, and sales. He joined ProofPilot as the CEO in 2022 after serving as the Chief Commercial Officer at Citeline Connect. ProofPilot has grown to become a major player in the clinical trial space over the past four years under Venezia’s leadership.
“Sponsors are looking for technology partners that can move as quickly and intelligently as trials demand,” said Chris Venezia. “RealTime eClinical Solutions is well-positioned to meet that need, and I’m excited to support the team as they expand the impact of the company’s technology for sponsors and study teams alike.”